Diagnostics — Operating Income
Labcorp Holdings Diagnostics — Operating Income increased by 9.4% to $458.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $427.50M to $458.70M. Over 4 years (FY 2021 to FY 2025), Diagnostics — Operating Income shows a downward trend with a -13.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates improved operational efficiency, higher test volume, or better pricing power within the diagnostic services market. A decrease may signal rising labor or supply costs, pricing pressure, or declining demand for laboratory services.
Detailed definition
This metric represents the profitability of the core laboratory testing and diagnostic services segment after accounting...
Peer comparison
Comparable to segment-level operating income reported by other large-scale clinical laboratory providers or healthcare diagnostic firms.
lh_segment_diagnostics_operating_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $801.40M | $801.40M | $801.40M | $683.10M | $515.60M | $439.80M | $387.00M | $441.50M | $409.70M | $386.30M | $353.80M | $417.90M | $441.50M | $387.40M | $359.50M | $427.50M | $482.80M | $450.40M | $419.20M | $458.70M |
| QoQ Change | — | +0.0% | +0.0% | -14.8% | -24.5% | -14.7% | -12.0% | +14.1% | -7.2% | -5.7% | -8.4% | +18.1% | +5.6% | -12.3% | -7.2% | +18.9% | +12.9% | -6.7% | -6.9% | +9.4% |
| YoY Change | — | — | — | — | -35.7% | -45.1% | -51.7% | -35.4% | -20.5% | -12.2% | -8.6% | -5.3% | +7.8% | +0.3% | +1.6% | +2.3% | +9.4% | +16.3% | +16.6% | +7.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's diagnostics — operating income?
- Labcorp Holdings (LH) reported diagnostics — operating income of $458.70M in Q1 2026.
- How has Labcorp Holdings's diagnostics — operating income changed year-over-year?
- Labcorp Holdings's diagnostics — operating income increased by 7.3% year-over-year, from $427.50M to $458.70M.
- What is the long-term trend for Labcorp Holdings's diagnostics — operating income?
- Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — operating income has grown at a -13.7% compound annual growth rate (CAGR), from $3.21B to $1.78B.
- What does diagnostics — operating income mean?
- The profit generated by the diagnostic testing business segment after subtracting direct operating expenses.